{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:04:45Z","timestamp":1790697885651,"version":"4.1.0"},"reference-count":26,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background: Histological grade is one of the strongest prognostic factors in invasive breast cancer. However, it remains unclear whether histological subtype provides additional prognostic information in well-differentiated (grade 1; G1) invasive breast carcinomas. This study investigated the distribution of histological subtypes in G1 breast cancers and evaluated their impact on overall survival. Methods: In this retrospective single-centre study, all patients diagnosed with G1 invasive breast carcinoma in a single institution between 2005 and 2014 were identified. Histopathological and clinical data were retrieved from institutional pathology and clinical databases. Tumours were classified as no special type (NST), pure special type, or mixed subtype. Overall survival was analysed using Kaplan\u2013Meier estimates and compared with the log-rank test. Associations between histological subtype and mortality were evaluated using the chi-squared test. Results: Of 429 initially identified patients, 364 fulfilled the inclusion criteria. NST represented the predominant subtype (67.3%), whereas pure special types and mixed subtypes accounted for 15.1% and 15.7% of cases, respectively. Tubular carcinoma was the most frequent pure special subtype, followed by mucinous, cribriform, papillary, lobular and adenoid cystic carcinoma. After exclusion of patients with simultaneous higher-grade contralateral carcinomas, 348 patients were included in survival analyses. The overall 5- and 10-year survival rates were 94.7% and 85.4%, respectively. Pure special types showed the highest survival rates numerically, whereas mixed subtypes had the lowest. However, overall survival did not differ significantly between NST, pure special types and mixed subtypes (log-rank p = 0.39). Likewise, no significant survival differences were observed among individual pure special subtypes (p = 0.20), and no significant association between histological subtype and mortality was identified (\u03c72\u00a0p = 0.064). Conclusions: Within this cohort of G1 invasive breast carcinomas, no statistically significant association between histological subtype and overall survival was identified. However, clinically relevant differences cannot be excluded given the heterogeneity of the cohort and the small number of events. Larger studies incorporating multivariable analyses and breast cancer-specific outcomes are needed to further clarify the prognostic relevance of histological subtype in G1 invasive breast cancer.<\/jats:p>","DOI":"10.3390\/cancers18193154","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:14:37Z","timestamp":1790694877000},"page":"3154","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Histological Subtype Provides Limited Prognostic Information in Grade 1 Invasive Breast Carcinoma: A Retrospective Cohort Study"],"prefix":"10.3390","volume":"18","author":[{"given":"Eleonore","family":"Locher","sequence":"first","affiliation":[{"name":"Department of Pathology and Molecular Pathology, University Hospital Zurich, 8091 Zurich, Switzerland"},{"name":"Internal Medicine, See-Spital Horgen, 8810 Horgen, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0477-368X","authenticated-orcid":false,"given":"Lara","family":"Benning","sequence":"additional","affiliation":[{"name":"Department of Pulmonology, University Hospital Zurich, 8091 Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2855-983X","authenticated-orcid":false,"given":"Zsuzsanna","family":"Varga","sequence":"additional","affiliation":[{"name":"Department of Pathology and Molecular Pathology, University Hospital Zurich, 8091 Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/01.JAA.0000580524.95733.3d","article-title":"Overview of breast cancer","volume":"32","author":"Watkins","year":"2019","journal-title":"JAAPA"},{"key":"ref_2","unstructured":"WHO Classification of Tumours Editorial Board (2026). WHO Classification of Breast Tumours, International Agency for Research on Cancer (IARC). [6th ed.]."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/bcr2607","article-title":"Breast cancer prognostic classification in the molecular era: The role of histological grade","volume":"12","author":"Rakha","year":"2010","journal-title":"Breast Cancer Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2559.1991.tb00229.x","article-title":"Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up","volume":"19","author":"Elston","year":"1991","journal-title":"Histopathology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2559.1992.tb01032.x","article-title":"Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long-term follow-up","volume":"20","author":"Ellis","year":"1992","journal-title":"Histopathology"},{"key":"ref_6","unstructured":"WHO Classification of Tumours Editorial Board (2019). WHO Classification of Tumours of the Breast, International Agency for Research on Cancer (IARC). [5th ed.]."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s10549-007-9768-4","article-title":"Histologic grading is an independent prognostic factor in invasive lobular carcinoma of the breast","volume":"111","author":"Rakha","year":"2008","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1200\/JCO.2007.15.5986","article-title":"Prognostic significance of Nottingham histologic grade in invasive breast carcinoma","volume":"26","author":"Rakha","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"ref_9","unstructured":"WHO Classification of Tumours Editorial Board (2012). WHO Classification of Tumours of the Breast, International Agency for Research on Cancer (IARC). [4th ed.]."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1093\/annonc\/mdp245","article-title":"Breast carcinoma\u2014Rare types: Review of the literature","volume":"20","author":"Yerushalmi","year":"2009","journal-title":"Ann. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Song, B., and Singh, H. (2024). Rare Breast Cancers Review. Healthcare, 12.","DOI":"10.3390\/healthcare12232483"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/1477-7819-11-139","article-title":"Pure mucinous carcinoma of the breast: Clinicopathologic characteristics and long-term outcome among Taiwanese women","volume":"11","author":"Tseng","year":"2013","journal-title":"World J. Surg. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.2217\/fon-2018-0385","article-title":"Tubular carcinomas of the breast: An epidemiologic study","volume":"14","author":"Sun","year":"2018","journal-title":"Future Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"4967","DOI":"10.1007\/s00432-022-04443-x","article-title":"Prognostic relevance of mixed histological subtypes in invasive breast carcinoma: A retrospective analysis","volume":"149","author":"Rechsteiner","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1200\/JCO.2009.23.5051","article-title":"Tubular carcinoma of the breast: Further evidence to support its excellent prognosis","volume":"28","author":"Rakha","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1365-2559.1995.tb00213.x","article-title":"Pathological prognostic factors in breast cancer. IV: Should you be a typer or a grader? A comparative study of two histological prognostic features in operable breast carcinoma","volume":"27","author":"Pereira","year":"1995","journal-title":"Histopathology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4137\/CPath.S31563","article-title":"Diversity of Breast Carcinoma: Histological Subtypes and Clinical Relevance","volume":"8","author":"Makki","year":"2015","journal-title":"Clin. Med. Insights Pathol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1001\/archinte.163.18.2149","article-title":"Risk of mortality by histologic type of breast cancer among women aged 50 to 79 years","volume":"163","author":"Li","year":"2003","journal-title":"Arch. Intern. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.breast.2020.09.006","article-title":"Clinicopathological characteristics and prognosis of breast cancer with special histological types: A surveillance, epidemiology, and end results database analysis","volume":"54","author":"Han","year":"2020","journal-title":"Breast"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/sj.bjc.6602787","article-title":"Clinical characteristics of different histologic types of breast cancer","volume":"93","author":"Li","year":"2005","journal-title":"Br. J. Cancer"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"5573148","DOI":"10.1155\/crip\/5573148","article-title":"Mucinous Micropapillary Carcinoma of Breast in a Developing World Setting: Case Series with Clinicopathological Insights and Survival Analysis from a Tertiary Care Hospital","volume":"2026","author":"Anjum","year":"2026","journal-title":"Case Rep. Pathol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Qiu, P., Cui, Q., Huang, S., Zhang, Y., Zhang, H., and Luo, H. (2024). An overview of invasive micropapillary carcinoma of the breast: Past, present, and future. Front. Oncol., 14.","DOI":"10.3389\/fonc.2024.1435421"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.21037\/gs-2025-417","article-title":"Male invasive breast carcinoma containing both mucinous and micropapillary components with axillary lymph node metastasis: A rare case report with literature review","volume":"15","author":"Zhao","year":"2026","journal-title":"Gland. Surg."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1365-2559.1983.tb02265.x","article-title":"Invasive cribriform carcinoma of the breast","volume":"7","author":"Page","year":"1983","journal-title":"Histopathology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4274\/ejbh.galenos.2023.2022-12-9","article-title":"Pure Tubular Breast Carcinoma: Clinicopathological Characteristics and Clinical Outcomes","volume":"19","author":"Emiroglu","year":"2023","journal-title":"Eur. J. Breast Health"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ejca.2017.01.034","article-title":"Pathological characterisation of male breast cancer: Results of the EORTC 10085\/TBCRC\/BIG\/NABCG International Male Breast Cancer Program","volume":"82","author":"Vermeulen","year":"2017","journal-title":"Eur. J. Cancer"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/19\/3154\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:20:08Z","timestamp":1790695208000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/19\/3154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,29]]},"references-count":26,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["cancers18193154"],"URL":"https:\/\/doi.org\/10.3390\/cancers18193154","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,29]]}}}